BIOCANRX CANADA'S IMMUNOTHERAPY NETWORK & DESIGN

View On IC.GC.CA

REGISTERED

on 28 Feb 2022

Last Applicant/ Owned by

BIOCANRX: BIOTHERAPEUTICS FOR CANCER TREATMENTS

501 Smyth RoadCCW-6189aOttawa

ONTARIO

K1H8L6

Serial Number

1911128 filed on 24^th Jul 2018

Registration Number

TMA1121223 registered on 28^th Feb 2022

Registration expiry Date

29^th Feb 2032

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

BIOCANRX CANADA'S IMMUNOTHERAPY NETWORK & DESIGN

Trademark usage description

electronic documents, namely, newsletters, media releases, discussion papers and other periodicals for scientists, clinicians, cancer stakeholders, ac Read More

Vienna Information

5 . 3 . 4

Vine leaves (except 5.3.19), plane leaves, maple leavesFeuilles de vigne (excepté 5.3.19), de platane, d'érable

5 . 3 . 51

Other maple leaf (leaves)Autres feuilles d'érable

5 . 3 . 14

One leafUne feuille

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

24 . 17 . 16

Prescription symbol (Rx)Symbole de prescription (Rx)

Classification Information

Class [009]
Electronic documents, namely, newsletters, media releases, discussion papers and other periodicals for scientists, clinicians, cancer stakeholders, academic institutions, non-government organizations, doctors, researchers, students, patients, industry and other parties related to cancer research in the field of cancer biotherapeutics.

Classification kind code

Class [016]
Printed publications, including newsletters, media releases, discussion papers and other periodicals, for scientists, clinicians, cancer stakeholders, academic institutions, non-government organizations, doctors, researchers, students, patients, industry and other parties related to cancer research in the field of cancer biotherapeutics.

Classification kind code

Class [036]
Providing funds investment for cancer research in the field of cancer biotherapeutics; Providing funds investment for the development of cancer therapies in the field of cancer biotherapeutics; Providing funds investment to students, researchers and research staff to conduct cancer research in the field of cancer biotherapeutics; Supporting cancer research in the field of cancer biotherapeutics; providing funds investment to students, researchers, research staff and patients to attend events related to cancer research in the field of cancer biotherapeutics; Providing funds investment to students, researchers, research staff and patients to attend educational exchanges related to cancer research in the field of cancer biotherapeutics; providing funds investment for the operation of facilities conducting cancer research in the field of cancer biotherapeutics.

Classification kind code

Class [041]
Developing, organizing and conducting conferences, training events, seminars, presentations, courses and workshops related to cancer research in the field of cancer biotherapeutics; supporting cancer research in the field of cancer biotherapeutics, namely, providing training in the field of cancer medical research.

Classification kind code

Class [042]
Providing information to scientists, clinicians, cancer stakeholders, academic institutions, non-government organizations, doctors, researchers, students, patients, industry and other parties related to cancer medical research in the field of cancer biotherapeutics; hosting a website for scientists, clinicians, cancer stakeholders, academic institutions, non-government organizations, doctors, researchers, students, patients, industry and other parties related to cancer research in the field of cancer biotherapeutics; supporting the development of cancer therapies in the field of cancer biotherapeutics, namely, research and development of cancer biomedical research.

Classification kind code

Mark Details

Serial Number

1911128

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 27 on 8^th Nov 2021	Approval Notice Sent
Submitted for opposition 23 on 2^th Nov 2021	Default Removed
Submitted for opposition 14 on 8^th Jun 2021	Default Notice Sent
Submitted for opposition 22 on 16^th Nov 2020	Search Recorded
Submitted for opposition 20 on 16^th Nov 2020	Examiner's First Report
Submitted for opposition 135 on 2^th Oct 2019	Amendment to Application
Submitted for opposition 90 on 14^th Aug 2018	Clerical Correction
Submitted for opposition 31 on 31^st Jul 2018	Formalized
Submitted for opposition 30 on 24^th Jul 2018	Filed
Submitted for opposition 1 on 24^th Jul 2018	Created